Evidence map›Paper›PMID 35347328›Full record

ArticleNature biotechnology2022

Accelerated identification of disease-causing variants with ultra-rapid nanopore genome sequencing.

Sneha D Goenka, John E Gorzynski, Kishwar Shafin, Dianna G Fisk, Trevor Pesout, Tanner D Jensen, Jean Monlong, Pi-Chuan Chang, Gunjan Baid, Jonathan A Bernstein and 19 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Quantitative metagenomics using a portable protocol.Applied and environmental microbiology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Proteomic Technology.Advances in experimental medicine and biology · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Long-term follow-up of children who received rapid genomic sequencing.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Sneha D Goenka *Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-1716-7769
John E Gorzynski *Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-9034-9016
Kishwar Shafin *UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.ORCID http://orcid.org/0000-0001-5252-3434
Dianna G FiskStanford Health Care, Palo Alto, CA, USA.
Trevor PesoutUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Tanner D JensenStanford University, Stanford, CA, USA.
Jean MonlongUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Pi-Chuan ChangGoogle Inc, Mountain View, CA, USA.ORCID http://orcid.org/0000-0003-3021-6446
Gunjan BaidGoogle Inc, Mountain View, CA, USA.
Jonathan A BernsteinStanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-5369-346X
Jeffrey W ChristleStanford University, Stanford, CA, USA.
Karen P DaltonStanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-2834-8001
Daniel R GaraldeOxford Nanopore Technologies, Oxford, UK.
Megan E GroveStanford Health Care, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0002-7972-0005
Joseph GuilloryOxford Nanopore Technologies, Oxford, UK.
Alexey KolesnikovGoogle Inc, Mountain View, CA, USA.
Maria NattestadGoogle Inc, Mountain View, CA, USA.
Maura R Z RuzhnikovStanford University, Stanford, CA, USA.
Mehrzad SamadiNVIDIA Corporation, Santa Clara, CA, USA.
Ankit SethiaNVIDIA Corporation, Santa Clara, CA, USA.
Elizabeth SpiteriStanford University, Stanford, CA, USA.
Christopher J WrightOxford Nanopore Technologies, Oxford, UK.
Katherine XiongStanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-1603-2037
Tong ZhuNVIDIA Corporation, Santa Clara, CA, USA.
Miten JainUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Fritz J SedlazeckBaylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6040-2691
Andrew CarrollGoogle Inc, Mountain View, CA, USA.ORCID http://orcid.org/0000-0002-4824-6689
Benedict PatenUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.ORCID http://orcid.org/0000-0001-8863-3539
Euan A AshleyStanford University, Stanford, CA, USA. euan@stanford.edu.ORCID http://orcid.org/0000-0001-9418-9577

Funding

The AnVIL Data Ecosystem DACReS SupplementU24HG010262 · NHGRI · BROAD INSTITUTE, INC. · PI Robert J Carroll, Jonathan Lawson · 2018 to 2026
$40.5M
The Integration of Trans-omics for Precision Medicine (TOPMED) and Other Heart, Lung, Blood and Sleep (HLBS) Data Sets with the Data CommonsOT3HL142481 · NHLBI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI GROSSMAN, ROBERT L., PATEN, BENEDICT · 2017 to 2020
$24.9M
Dockstore: The Community Platform for Reproducible Biomedical Workflows and ApplicationsU24HG011853 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Jonathan Lawson, Benedict Paten · 2021 to 2026
$5.7M
Comprehensive, Flexible and FAIR Tools for the HuBMAP HIVEOT2OD026682 · OD · CARNEGIE-MELLON UNIVERSITY · PI PATEN, BENEDICT, RUFFALO, MATTHEW · 2018 to 2021
$3.4M
The construction and utility of reference pan-genome graphsU01HG010961 · NHGRI · DANA-FARBER CANCER INST · PI LI, HENG, PATEN, BENEDICT · 2020 to 2023
$3.2M
Enabling Comparative PangenomicsR01HG010485 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H, MARTIN, FERGAL JAMES · 2020 to 2023
$2.6M
NHGRI NIH HHS R01 HG010485NHGRI NIH HHS U01 HG010961NHGRI NIH HHS U24 HG010262NHGRI NIH HHS U24 HG011853NHLBI NIH HHS OT3 HL142481NIH HHS OT2 OD026682
6 · The paper itself

Abstract

Whole-genome sequencing (WGS) can identify variants that cause genetic disease, but the time required for sequencing and analysis has been a barrier to its use in acutely ill patients. In the present study, we develop an approach for ultra-rapid nanopore WGS that combines an optimized sample preparation protocol, distributing sequencing over 48 flow cells, near real-time base calling and alignment, accelerated variant calling and fast variant filtration for efficient manual review. Application to two example clinical cases identified a candidate variant in <8 h from sample preparation to variant identification. We show that this framework provides accurate variant calls and efficient prioritization, and accelerates diagnostic clinical genome sequencing twofold compared with previous approaches.

Indexed as

NanoporesNanopore SequencingChromosome MappingHigh-Throughput Nucleotide SequencingHumansWhole Genome Sequencing

Identifiers

PMID35347328
PMCPMC9287171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.